Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.0 g/kg - molluscicide - flowers - seedlings & mature crops | home garden use - general | potted plants - seedlings & mature crops | vegetable - seedling - slug | snail | bradybaena similaris | helix aspersa | sigmurethra | theba pisana

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

j c & a t searle pty ltd - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.0 g/kg - molluscicide

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - indications and usage tramadol hydrochloride is indicated for the management of moderate to moderately severe pain in adults. contraindications tramadol hydrochloride should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride may worsen central nervous system and respiratory depression in these patients. pediatric use the safety and efficacy of tramadol hydrochloride in patients under 16 years of age have not been established. the use of tramadol hydrochloride in the pediatric population is not recommended. geriatric use in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range,

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine hydrochloride 10 mg - cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hydrochloride tablets should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao) inhibito

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 600 mg - indications and usage carefully consider the potential benefits and risks of ibuprofen tablets, usp and other treatment options before deciding to use ibuprofen tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). ibuprofen tablets, usp are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets, usp are indicated for relief of mild to moderate pain. ibuprofen tablets, usp are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets, usp in children have not been conducted. contraindications ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, an

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 300 mg - indications and usage postherpetic neuralgia gabapentin is indicated for the management of postherpetic neuralgia in adults. epilepsy gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. gabapentin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 – 12 years. contraindications gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pediatric use safety and effectiveness of gabapentin in the management of postherpetic neuralgia in pediatric patients have not been established. effectiveness as adjunctive therapy in the treatment of partial seizures in pediatric patients below the age of 3 years has not been established (see clinical pharmacology, clinical studies). geriatric use the total number of patients treated with gabapentin in controlled cl

United States - English - NLM (National Library of Medicine)

elorac, inc. - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline tablets and other antibacterial drugs, doxycycline tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections:   rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae .   respiratory tract infections caused by mycoplasma pneumoniae .   lymphogranuloma venereum caused by chlamydia trachomatis .   psittacosis (ornithosis) caused by chlamydophila psittaci .   trachoma caused by chlamydia trachomatis, although the infectious agent is not alw

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الحياة للصناعات الدوائية - hayat pharmaceutical industries co.plc - cholecalciferol 60,000 iu - 60,000 iu

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - levothyroxine (unii: q51bo43mg4) (levothyroxine - unii:q51bo43mg4), liothyronine (unii: 06lu7c9h1v) (liothyronine - unii:06lu7c9h1v) - indications and usage: np thyroid® tablets (thyroid tablets, usp) are indicated: 1. as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (see warnings). 2. as pituitary tsh suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (hashimoto’s), multinodular goiter, and in the management of thyroid cancer. contraindications: thyroid hormone preparations are generally

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.2 g/kg - molluscicide - around plants - general | oilseed crop | pasture establishment | pulse crop | winter cereal | barley | oats | ornamental plants - common garden vine snail | common slug | snail | snail - see label for exceptions | white italian snail | bradybaena similaris | deroceras caruanae | helix aspersa | sigmurethra | theba pisana | vineyard snail